Find clinical trials for Multiple Myeloma in Jacksonville, FL
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Multiple Myeloma trials near Jacksonville, FL, USA:
This is a phase 1, multicenter, open-label study evaluating the safety and efficacy of ruxolitinib, steroids and lenalidomide among MM patients who c...
Phase 1
Jacksonville, Florida, United States and 12 other locations
is a Phase 1b/2, open-label, multicenter study of AZD0120, a CD19/BCMA dual CAR T-cell therapy, in adult subjects with relapsed/refractory multiple...
Phase 1, Phase 2
Jacksonville, Florida, United States and 35 other locations
Open-Label, Study to Investigate the Safety and Efficacy of CLN-619 (anti-MICA/MICB Antibody) in Patients with Relapsed and Refractory Multiple...
Phase 1
Jacksonville, Florida, United States and 7 other locations
versus standard regimens in subjects with relapsed and refractory multiple myeloma (RRMM).The study is anticipated to randomize app...
Phase 3
Jacksonville, Florida, United States and 59 other locations
Multiple myeloma (MM) is a cancer of the blood's plasma cells. The cancer is typically found in the bones and bone marrow (the spon...
Phase 1
Jacksonville, Florida, United States and 14 other locations
of this study is to evaluate the effectiveness and safety of Arlocabtagene Autoleucel (BMS-986393) in participants with relapsed or refractory multiple...
Phase 2
Jacksonville, Florida, United States and 51 other locations
of care therapy (SOCT) in participants with relapsed/refractory multiple myeloma who have received 1 to 3 prior lines of therapy, i...
Phase 3
Jacksonville, Florida, United States and 123 other locations
with Relapsed/Refractory (r/r) Non-Hodgkin's Lymphoma (NHL) or Multiple Myeloma (MM). Cemsidomide may be administered as a single a...
Phase 1
Jacksonville, Florida, United States and 12 other locations
antibody (mAb). Renal impairment is a major complication of multiple myeloma (MM) and the majority of MM participants is either at ...
Phase 1
Jacksonville, Florida, United States and 18 other locations
(BMS-986393) in combinations with alnuctamab, mezigdomide, iberdomide, and elranatamab in participants with relapsed and/or refractory multiple...
Phase 1
Jacksonville, Florida, United States and 18 other locations
Clinical trials
Research sites
Resources
Legal